Stock Events

HST Global 

$1.1
3
+$0.06+5.77% Today

Statistics

Day High
1.05
Day Low
1.05
52W High
1.15
52W Low
0.17
Volume
600
Avg. Volume
309
Mkt Cap
43.64M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

30SepConfirmed
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0.02
-0.01
-0.01
-0.01
Expected EPS
N/A
Actual EPS
-0.0067

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HSTC. It's not an investment recommendation.
Alphabet
68918
GOOGL
Apple
60554
AAPL
Microsoft
56693
MSFT
Amazon
51850
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap177.72B
Amgen is a biotechnology firm involved in the development of treatments that could potentially compete with HST Global's cancer therapies.
Gilead Sciences
GILD
Mkt Cap90.4B
Gilead Sciences operates in the biopharmaceutical field focusing on drugs, including cancer treatments, which could directly compete with HST Global's products.
Merck &
MRK
Mkt Cap318.55B
Merck is a global healthcare company that produces cancer drugs and therapies, competing in the same market as HST Global.
Pfizer
PFE
Mkt Cap169.83B
Pfizer is involved in the development and manufacturing of healthcare products, including cancer treatments, which positions them as a competitor to HST Global.
Bristol-Myers Squibb
BMY
Mkt Cap86.44B
Bristol-Myers Squibb specializes in biopharmaceuticals, including cancer drugs, competing in the oncology sector with HST Global.
Novartis
NVS
Mkt Cap232.42B
Novartis is a multinational pharmaceutical company that develops and sells drugs, including those for cancer, which competes with HST Global's offerings.
Lilly(Eli) &
LLY
Mkt Cap814.94B
Eli Lilly and Company develops pharmaceutical products, including cancer treatments, which makes them a direct competitor to HST Global.
Johnson & Johnson
JNJ
Mkt Cap372.29B
Johnson & Johnson operates in the healthcare sector, offering products and treatments for various diseases, including cancer, competing with HST Global.
Abbvie
ABBV
Mkt Cap304.29B
AbbVie is a biopharmaceutical company that develops and markets therapies, including for cancer, which competes with HST Global.
Roche
RHHBY
Mkt Cap220.72B
Roche Holding AG is a major player in diagnostics and pharmaceuticals, including cancer treatments, directly competing with HST Global in the oncology market.

About

Miscellaneous Commercial Services
Commercial Services
Health Services
Hospital/Nursing Management
Manufacturing
Pharmaceutical Preparation Manufacturing
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life-threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.
Show more...
CEO
Country
US
ISIN
US40432E2028

Listings

OTCM
US
HSTC